Catherine Mackey

Catherine J.
Mackey is currently Chief Executive Officer at Cyprus Therapeutics, Inc. since 2015.
Serving as Director at Rady Children's Health since 2006.
Holds the position of Director-Emeritus at San Diego Athena.
Independent Director at Voyager Therapeutics, Inc. and IDEAYA Biosciences, Inc. since 2022.
Formerly Chairman at Cour Pharmaceuticals Development Co., Inc. from 2014 to 2022.
Director at Sequenom, Inc. from 2015 to 2016.
Independent Director at YM BioSciences, Inc. from 2012 to 2013.
Director at Viventia Biotech, Inc., Genelux Corp., Ajinomoto Althea, Inc., CONNECT, Biocom, Inc. Former Director at Trillium Therapeutics, Inc. in 2021.
Independent Non-Executive Director at GW Pharmaceuticals Ltd. from 2017 to 2021.
Director at Viventia Bio, Inc. from 2015 to 2016.
Independent Director at Poseida Therapeutics, Inc. from 2019 to 2021.
Independent Director at Avid Bioservices, Inc. from 2019 to 2025.
Director at Project Concern International from 2007 to 2024.
Director at Infinant Health, Inc. from 2014 to 2017.
Director at Rady Children's Institute for Genomic Medicine from 2015 to 2024.
Vice President at DEKALB Genetics Corp.
from 1990 to 1998.
Senior VP-Worldwide Research & Development at Pfizer Inc. from 2001 to 2010.
Education includes undergraduate degree conferred in 1977 and doctorate degree conferred in 1983, both from Cornell University.